S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   163.42 (-3.97%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
GILD   72.70 (-2.68%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   163.42 (-3.97%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
GILD   72.70 (-2.68%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   163.42 (-3.97%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
GILD   72.70 (-2.68%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   210.98 (-2.54%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   163.42 (-3.97%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.41 (-7.11%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
GE   10.38 (-5.21%)
TSLA   679.00 (-12.81%)
T   35.71 (-3.75%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   117.97 (-4.37%)
GILD   72.70 (-2.68%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Oncolytics BiotechCumberland PharmaceuticalsEyenoviaAclaris TherapeuticsNewLink Genetics
SymbolNASDAQ:ONCYNASDAQ:CPIXNASDAQ:EYENNASDAQ:ACRSNASDAQ:NLNK
Price Information
Current Price$2.18$4.10$3.57$1.11$1.47
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$9.00$9.75$9.50$9.00$4.00
% Upside from Price Target312.84% upside137.80% upside166.11% upside710.81% upside172.11% upside
Trade Information
Market Cap$76.63 million$64.38 million$68.56 million$56.70 million$54.87 million
Beta2.990.141.451.061.24
Average Volume907,7477,05131,513758,681394,984
Sales & Book Value
Annual RevenueN/A$40.74 millionN/A$4.23 million$12.47 million
Price / SalesN/A1.53N/A10.864.40
CashflowN/A$0.07 per shareN/AN/AN/A
Price / CashN/A56.71N/AN/AN/A
Book Value$0.27 per share$3.58 per share$1.43 per share$5.26 per share$3.09 per share
Price / BookN/A1.15N/A0.210.48
Profitability
Net Income$-13,140,000.00$-6,960,000.00$-17,250,000.00$-132,740,000.00$-53,600,000.00
EPS($0.82)($0.12)($1.82)($2.25)($1.44)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A205.00N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-10.13%N/A-1,242.71%-6,423.69%
Return on Equity (ROE)-388.43%6.76%-165.66%-81.23%-40.06%
Return on Assets (ROA)-118.37%3.33%-138.20%-52.12%-33.45%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.07%0.39%N/A0.35%N/A
Current Ratio3.78%2.35%7.68%3.73%7.31%
Quick Ratio3.78%1.88%7.68%3.73%7.31%
Ownership Information
Institutional Ownership Percentage1.19%30.00%7.13%74.49%32.32%
Insider Ownership Percentage0.10%39.38%43.10%14.80%12.70%
Miscellaneous
EmployeesN/A80N/A16955
Shares Outstanding32.20 million15.18 million16.44 million41.39 million37.33 million
Next Earnings Date3/13/2020 (Estimated)5/12/2020 (Estimated)3/25/2020 (Estimated)5/13/2020 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel